Ya-Ling Han

Showing 1-7 of 7 articles

Coronary interventions

Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial

Zhang Y-J, Wang X-Z, Fu G, Jing Q, Wang G, Jin C-Y, Xie L-H, Cai J-Z, Xu B, Han Y-L

November 20, 2016 | 10.4244/EIJV12I10A209

Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study

Xu B, Yang Y, Han Y-L, Lu S-Z, Li B, Liu Q, Zhu G-Y, Cui J-Y, Li L, Zhao Y-L, Kirtane A

May 20, 2014 | 10.4244/EIJV10I1A12

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y-L, Zhong S-L

September 27, 2013 | 10.4244/EIJV9I5A90

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation

Liang Z-Y, Han Y-L, Zhang X-L, Li Y, Yan C-H, Kang J

July 26, 2013 | 10.4244/EIJV9I3A53

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

Gao R, Xu B, Lansky A, Yang Y, Ma C-S, Han Y-L, Chen S-L, Li H, Zhang R, Fu G, Yuan Z, Jiang H, Huo Y, Li W, Zhang Y-J, Leon M

May 21, 2013 | 10.4244/EIJV9I1A12

Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study

Zhu X-Y, Qin Y, Han Y-L, Zhang D-Z, Wang P, Liu Y-F, Xu Y-W, Jing Q, Xu K, Gersh B, Wang X-Z

March 22, 2013 | 10.4244/EIJV8I11A195

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study

Han Y-L, Zhang L, Yang L-X, Liu H-L, Qu P, Li W-M, Jiang T, Li S-M, Jing Q, Zhang Q-Y, Xu B, Li Y, Gao R

November 20, 2012 | 10.4244/EIJV8I7A124

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Hinge point-based aortic annular plane

September 18, 2020

Ahead of print: Histopathology of embolic debris during TAVI

September 18, 2020

Transcatheter VIV implantation for failed surgical bioprostheses

September 18, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Over 10,000 followers

September 18, 2020

Steady-state hyperaemia: many routes, one goal

September 18, 2020

This Week's JAA's: Leaflex study, Coronary access after REDO-TAVI...

September 15, 2020

Valvular disease